Bellinzona, Switzerland

Antonio Lanzavecchia

USPTO Granted Patents = 64 

 

 

Average Co-Inventor Count = 2.3

ph-index = 13

Forward Citations = 481(Granted Patents)

Forward Citations (Not Self Cited) = 158(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • Porza, CH (2011 - 2022)
  • Bellinzona, CH (2010 - 2024)

Company Filing History:


Years Active: 2010-2025

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Neutralizing Antibodies
Prefusion Immunogens
Self-Assembling Protein Nanostructures
Recombinant Proteins
HIV Binding Agents
Human Cytomegalovirus
Influenza Virus
Dengue Virus
Multispecific Antibodies
T Cell Modulators
Ebola Virus
Monoclonal Antibody Production
64 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Antonio Lanzavecchia

Introduction

Antonio Lanzavecchia, a prominent innovator and inventor based in Bellinzona, Switzerland, has made significant contributions to the field of immunology with a remarkable portfolio of 60 patents. His groundbreaking work primarily focuses on advancing therapeutic strategies against viral infections, particularly those caused by the metapneumovirus and influenza A virus.

Latest Patents

Among his latest innovations, Lanzavecchia has developed the following notable patents:

1. **Recombinant Metapneumovirus F Proteins and Their Use** - This patent discloses metapneumovirus F proteins that are stabilized in a prefusion conformation, along with nucleic acid molecules and vectors for encoding these proteins. These innovations have far-reaching applications, particularly in generating an immune response to metapneumovirus in subjects. The therapeutic use of these F ectodomain trimers and/or nucleic acid molecules presents promising methodologies for treating or preventing MPV infections.

2. **Neutralizing Anti-Influenza A Antibodies and Uses Thereof** - This invention covers antibodies and binding fragments capable of targeting influenza A virus hemagglutinin. These antibodies exhibit neutralizing capabilities against various subtypes of the influenza A virus, presenting a significant advancement in combating flu-related infections.

Career Highlights

Lanzavecchia's professional journey has been marked by his association with esteemed research institutions one of which includes the Institute for Research in Biomedicine. Additionally, he contributed to the advancements at Humabs Biomed SA, where his innovative work led to the development of cutting-edge therapeutic solutions.

Collaborations

Throughout his career, Antonio Lanzavecchia has collaborated with several notable figures in the field, including esteemed coworkers such as Annalisa Macagno and Davide Corti. Their collective efforts have resulted in several key innovations and advancements in immunology.

Conclusion

Antonio Lanzavecchia’s dedication to advancing medical science is evident through his substantial number of patents and collaborations. His inventions continue to impact the understanding and treatment of viral infections, solidifying his reputation as a leading inventor in the field of immunology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…